The author presents a review about the protective efficacy of polyvalent pneumococcal polysaccharide vaccines in different groups at high risk for severe pneumococcal infection and the difficulties in the development of a conjugate pneumococcal vaccine capable of offering protection to younger children.
Journal Information
Vol. 70. Issue 02.
Pages 75-81 (March - April 1994)
Vol. 70. Issue 02.
Pages 75-81 (March - April 1994)
DOI: 10.2223/JPED.726
Full text access
Vacina Anti-Pneumocócica: eficácia em diferentes grupos de risco e recentes avanços no desenvolvimento de uma vacina mais imunogênica - Atualização
Visits
1224
This item has received
Article information
Abstract
Full text is only available in PDF